Obviousness Doomed Narcan Patents After NJ Bench Trial
Teva Pharmaceuticals proved that claims from four patents covering Adapt Pharma's opioid overdose medication Narcan are obvious, and the drug's success can't override that finding, a New Jersey federal judge said...To view the full article, register now.
Already a subscriber? Click here to view full article